Type 2 diabetes affects almost 200 million people around the world. The most common cause of this disease is excessive body weight. If this weight can be reduced, it improves the body’s ability to regulate blood glucose levels. In a recent clinical trial of acomplia involving more than one thousand participants in eleven countries, acomplia was found to reduce weight and give significantly better blood glucose control than the placebo. As the body weight decreased, blood pressure levels improved and the chances of heart disease were reduced. Thus, the general health of all participants with diabetes was improved by the combination of acomplia, a healthy diet and some physical exercise.